Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT02872792
Other study ID # 2014/211/HP
Secondary ID
Status Terminated
Phase N/A
First received
Last updated
Start date December 14, 2016
Est. completion date April 21, 2020

Study information

Verified date March 2022
Source University Hospital, Rouen
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Cycloergometer is a validated method for different care. This kind of device allow passive and active care for patient. The interest of cycloergometer for patient hospitalized in Intensive Care Unit for Sepsis has never been demonstrated. The main objective of this study is to determine the impact of early mobilization by cyclo-ergometer in association with standard physiotherapy, on the ICU length in patients with septic shock The secondary objectives of this study are to assess the impact of early mobilization by cyclo-ergometer in association with standard physiotherapy on: 1. the duration between hemodynamic stability* and the removal of sedation 2. the duration between the removal of sedation and ICU discharge 3. the mechanical ventilation duration (invasive and noninvasive)


Recruitment information / eligibility

Status Terminated
Enrollment 122
Est. completion date April 21, 2020
Est. primary completion date April 21, 2020
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Patient hospitalized in ICU - Septic shock diagnosed more than 24 hours before inclusion - Patient hemodynamically stable, before the 72th hour following the diagnosis of septic shock - Mechanical ventilation by tracheal intubation - Patient sedated with a RASS score inferior or equal to -2 - Age = 18 years - BMI = 40 kg / m² - Informed patient having signed the consent - Effective contraception in women of childbearing age (pregnancy test by B-HCG will be done; for menopausal women, a diagnosis of confirmation must be obtained). Exclusion Criteria: - BMI> 40kg / m² - Patient reduced by one or two lower limbs - Rheumatological pathology, trauma or surgery of the lower limbs, pelvis or spine resulting of any limitations of the range of motions or strict immobilization - Brain-injured patient and / or medulla injured - Hemodialysis continues with a femoral catheter without possibility of changing the catheter location - Moribund patient, Stop or Limitation of Active Therapeutics' decision - Contraindications to standard physical therapy or the cyclo-ergometer - Untreated orthopedics: deep vein thrombosis of the member concerned - Dermatological: severe lesions or complex dressings in the sector concerned - Patient with ExtraCorporeal Membrane Oxygenation (ECMO) - Pregnant or breastfeeding women - Patient participating in another trial with the same main objective

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Early mobilisation with cyclo ergometer
Early mobilisation with cyclo ergometer is done daily during hospitalization for sepsis in an Intensive Care Unit
Other:
Standard physiotherapy
Standard physiotherapy included passive and active manual mobilization, sitting on bed, sitting in chair, walking

Locations

Country Name City State
France Rouen University Hospital Rouen

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Rouen

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Number of days between hemodynamic stability and ICU discharge Number of days between hemodynamic stability (after beginning of hospitalization for sepsis) and ICU discharge approximately 1 month
Secondary Number of days between hemodynamic stability and the removal of sedation Number of days between hemodynamic stability (after beginning of hospitalization for sepsis) and the removal of sedation From 3 to 10 days
Secondary Number of days under mechanical ventilation (invasive and noninvasive) during hospitalization in ICU Number of days under mechanical ventilation (invasive and noninvasive, (after beginning of hospitalization for sepsis) ) during hospitalization in ICU From 3 to 10 days
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05095324 - The Biomarker Prediction Model of Septic Risk in Infected Patients
Completed NCT02714595 - Study of Cefiderocol (S-649266) or Best Available Therapy for the Treatment of Severe Infections Caused by Carbapenem-resistant Gram-negative Pathogens Phase 3
Completed NCT03644030 - Phase Angle, Lean Body Mass Index and Tissue Edema and Immediate Outcome of Cardiac Surgery Patients
Completed NCT02867267 - The Efficacy and Safety of Ta1 for Sepsis Phase 3
Completed NCT04804306 - Sepsis Post Market Clinical Utility Simple Endpoint Study - HUMC
Recruiting NCT05578196 - Fecal Microbial Transplantation in Critically Ill Patients With Severe Infections. N/A
Terminated NCT04117568 - The Role of Emergency Neutrophils and Glycans in Postoperative and Septic Patients
Completed NCT03550794 - Thiamine as a Renal Protective Agent in Septic Shock Phase 2
Completed NCT04332861 - Evaluation of Infection in Obstructing Urolithiasis
Completed NCT04227652 - Control of Fever in Septic Patients N/A
Enrolling by invitation NCT05052203 - Researching the Effects of Sepsis on Quality Of Life, Vitality, Epigenome and Gene Expression During RecoverY From Sepsis
Terminated NCT03335124 - The Effect of Vitamin C, Thiamine and Hydrocortisone on Clinical Course and Outcome in Patients With Severe Sepsis and Septic Shock Phase 4
Recruiting NCT04005001 - Machine Learning Sepsis Alert Notification Using Clinical Data Phase 2
Completed NCT03258684 - Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Sepsis and Septic Shock N/A
Recruiting NCT05217836 - Iron Metabolism Disorders in Patients With Sepsis or Septic Shock.
Completed NCT05018546 - Safety and Efficacy of Different Irrigation System in Retrograde Intrarenal Surgery N/A
Completed NCT03295825 - Heparin Binding Protein in Early Sepsis Diagnosis N/A
Not yet recruiting NCT06045130 - PUFAs in Preterm Infants
Not yet recruiting NCT05361135 - 18-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in S. Aureus Bacteraemia N/A
Not yet recruiting NCT05443854 - Impact of Aminoglycosides-based Antibiotics Combination and Protective Isolation on Outcomes in Critically-ill Neutropenic Patients With Sepsis: (Combination-Lock01) Phase 3